Trials / Sponsors / Xspray Pharma AB
Xspray Pharma AB
Industry · 6 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | A Bioavailability Study of Nilotinib in Healthy, Adult, Human Subjects Under Fasted Conditions. Cancer | Phase 1 | 2024-11-15 |
| Completed | Bioavailability Study of XS003 (Nilotinib) Cancer | Phase 1 | 2024-10-03 |
| Completed | An Drug-drug Interaction Study to Evaluate the Effects of Omeprazole 40mg on the Pharmacokinetics of SPRYCEL® Drug-drug Interaction Study | Phase 1 | 2023-08-22 |
| Completed | Comparative Bioavailability of XS004 (Dasatinib) Formulation G and SPRYCEL® (Dasatinib) in Healthy, Adult Subj Biological Availability | Phase 1 | 2021-06-07 |
| Completed | Evaluating the Effects of Omeprazole on the Pharmacokinetics of XS004 (Dasatinib) Tablets in Healthy Adult Sub Pharmacokinetics, Drug Interactions | Phase 1 | 2020-11-01 |
| Completed | Evaluating the Pharmacokinetic Parameters and Relative Bioavailability of Sorafenib (XS005) in Healthy Male Su Pharmacokinetics, Bioavailability | Phase 1 | 2018-11-16 |